{"component": "clause", "props": {"groups": [{"samples": [{"hash": "8QbBEs9drOw", "uri": "/contracts/8QbBEs9drOw#financial-appendix", "label": "Collaboration Agreement", "score": 31.340862423, "published": true}, {"hash": "68uOAXwhvIt", "uri": "/contracts/68uOAXwhvIt#financial-appendix", "label": "Collaboration Agreement (Exelixis Inc)", "score": 19.0, "published": true}], "size": 3, "snippet_links": [{"key": "reporting-of", "type": "clause", "offset": [34, 46]}, {"key": "operating-profits", "type": "clause", "offset": [47, 64]}, {"key": "the-financial", "type": "clause", "offset": [91, 104]}, {"key": "applicable-to", "type": "clause", "offset": [141, 154]}, {"key": "revenues-and-expenses", "type": "clause", "offset": [155, 176]}, {"key": "by-a-party", "type": "clause", "offset": [177, 187]}, {"key": "in-the-united-states", "type": "clause", "offset": [188, 208]}, {"key": "the-definitions", "type": "definition", "offset": [254, 269]}, {"key": "comply-with", "type": "clause", "offset": [297, 308]}, {"key": "changes-to-gaap", "type": "clause", "offset": [309, 324]}, {"key": "financial-accounting-standards", "type": "clause", "offset": [351, 381]}, {"key": "consistent-with-the", "type": "clause", "offset": [423, 442]}, {"key": "cost-sharing-ratio", "type": "definition", "offset": [450, 468]}, {"key": "the-material", "type": "definition", "offset": [478, 490]}], "snippet": "Terms describing calculations and reporting of Operating Profits (Losses) are set forth in the Financial Appendix. The Financial Appendix is applicable to revenues and expenses by a Party in the United States. For revenues and expenses by a Sublicensee, the definitions may need to be modified to comply with changes to GAAP or to comply with ex-U.S. financial accounting standards. Any such modification, however, will be consistent with the agreed Cost Sharing Ratio and with the material concepts in the existing Financial Appendix.", "hash": "d15a8814c0b1b879820b18ffb5d47bef", "id": 1}, {"samples": [{"hash": "1bVT5z5hEpS", "uri": "/contracts/1bVT5z5hEpS#financial-appendix", "label": "Contract", "score": 20.5770020534, "published": true}, {"hash": "6NcKm91fmR0", "uri": "/contracts/6NcKm91fmR0#financial-appendix", "label": "Contract", "score": 20.1211498973, "published": true}], "size": 2, "snippet_links": [{"key": "payment-plans", "type": "clause", "offset": [21, 34]}, {"key": "and-support", "type": "clause", "offset": [50, 61]}, {"key": "prior-to-the", "type": "clause", "offset": [122, 134]}, {"key": "phase-c", "type": "definition", "offset": [144, 151]}], "snippet": "The agreed Milestone Payment Plans for phases C/D and support to phase E1 are indicative and will be finally consolidated prior to the start of phase C/D and phase E1 respectively", "hash": "c568843ccd1596ab008a61827e169d2a", "id": 2}, {"samples": [{"hash": "da9aBQllr7S", "uri": "/contracts/da9aBQllr7S#financial-appendix", "label": "License, Development, and Commercialization Agreement (Prothena Corp PLC)", "score": 25.4271047228, "published": true}, {"hash": "jWF7rQ6VTwU", "uri": "/contracts/jWF7rQ6VTwU#financial-appendix", "label": "License, Development, and Commercialization Agreement (Prothena Corp PLC)", "score": 25.1779603012, "published": true}], "size": 2, "snippet_links": [{"key": "this-exhibit", "type": "definition", "offset": [16, 28]}, {"key": "of-operations", "type": "clause", "offset": [63, 76]}, {"key": "the-collaboration", "type": "clause", "offset": [81, 98]}, {"key": "territory-shall", "type": "definition", "offset": [113, 128]}, {"key": "legal-entity", "type": "definition", "offset": [195, 207]}, {"key": "meaning-of", "type": "clause", "offset": [237, 247]}, {"key": "tax-laws", "type": "clause", "offset": [252, 260]}, {"key": "financial-planning", "type": "clause", "offset": [355, 373]}, {"key": "policies-and-procedures-to-be-followed", "type": "clause", "offset": [386, 424]}, {"key": "profits-and-losses", "type": "definition", "offset": [440, 458]}, {"key": "revenue-and-expenses", "type": "clause", "offset": [483, 503]}, {"key": "terms-not-defined", "type": "definition", "offset": [637, 654]}, {"key": "the-meanings", "type": "definition", "offset": [682, 694]}, {"key": "article-1", "type": "definition", "offset": [708, 717]}, {"key": "this-agreement", "type": "clause", "offset": [733, 747]}, {"key": "the-principles", "type": "clause", "offset": [773, 787]}, {"key": "actual-results", "type": "definition", "offset": [802, 816]}, {"key": "combined-operations", "type": "clause", "offset": [843, 862]}, {"key": "frequency-of-reporting", "type": "clause", "offset": [921, 943]}, {"key": "currency-for", "type": "definition", "offset": [976, 988]}, {"key": "payments-to-the", "type": "clause", "offset": [1031, 1046]}, {"key": "auditing-of-accounts", "type": "clause", "offset": [1073, 1093]}], "snippet": "For purposes of this Exhibit only, the consolidated accounting of operations for the collaboration in the Shared Territory shall be referred to as the \u201cCollaboration\u201d. The Collaboration is not a legal entity, or a partnership within the meaning of any tax laws, and has been defined for identification purposes only. This Financial Appendix addresses the financial planning, accounting policies and procedures to be followed in determining Profits and Losses, and related sharing of revenue and expenses, in the Shared Territory between Roche Nutley and Prothena US (for purposes of this Exhibit 1.35 only, the \u201cCollaboration Parties\u201d). Terms not defined in this Exhibit shall have the meanings set forth in Article 1 of the body of this Agreement. This Exhibit sets forth the principles for reporting actual results and budgeted plans of the combined operations by the Collaboration Parties in the Shared Territory, the frequency of reporting, the use of a single functional currency for reporting, and the methods of determining payments to the Collaboration Parties and auditing of accounts.", "hash": "91801fd33fce7dc8dadf137cd0b66aa9", "id": 3}, {"samples": [{"hash": "1MHC3eTzhPB", "uri": "/contracts/1MHC3eTzhPB#financial-appendix", "label": "Collaboration Agreement (Arrowhead Research Corp)", "score": 22.9657768652, "published": true}, {"hash": "l0IxNaj9yv9", "uri": "/contracts/l0IxNaj9yv9#financial-appendix", "label": "Collaboration Agreement (Alnylam Pharmaceuticals, Inc.)", "score": 21.1533196441, "published": true}], "size": 2, "snippet_links": [{"key": "exhibit-e", "type": "definition", "offset": [5, 14]}, {"key": "the-principles", "type": "clause", "offset": [26, 40]}, {"key": "development-costs", "type": "definition", "offset": [84, 101]}, {"key": "commercialization-costs", "type": "definition", "offset": [103, 126]}, {"key": "profit-sharing", "type": "definition", "offset": [132, 146]}, {"key": "responsible-for", "type": "clause", "offset": [163, 178]}, {"key": "other-costs", "type": "clause", "offset": [183, 194]}, {"key": "with-respect-to", "type": "clause", "offset": [195, 210]}, {"key": "actual-results", "type": "definition", "offset": [305, 319]}, {"key": "in-the-united-states", "type": "clause", "offset": [339, 359]}, {"key": "frequency-of-reporting", "type": "clause", "offset": [365, 387]}, {"key": "functional-currency", "type": "clause", "offset": [410, 429]}, {"key": "foreign-exchange", "type": "clause", "offset": [462, 478]}, {"key": "the-parties", "type": "definition", "offset": [530, 541]}, {"key": "auditing-of-accounts", "type": "clause", "offset": [543, 563]}, {"key": "and-other-matters", "type": "clause", "offset": [564, 581]}], "snippet": "This Exhibit E sets forth the principles for capturing, reporting and consolidating Development Costs, Commercialization Costs, and Profit sharing. Roche shall be responsible for all other costs with respect to Licensed Product(s). For such purpose, this Exhibit E sets forth the principles for reporting actual results and budgeted plans in the United States, the frequency of reporting, the use of a single \u201cFunctional Currency\u201d (as defined under the heading \u201cForeign Exchange\u201d below) and the methods of determining payments to the Parties, auditing of accounts and other matters.", "hash": "413141aba4a2822827c14971f82c8f07", "id": 4}, {"samples": [{"hash": "7P4lYNj8zHx", "uri": "/contracts/7P4lYNj8zHx#financial-appendix", "label": "Development, Promotion, Distribution and Supply Agreement (Imclone Systems Inc/De)", "score": 18.0, "published": true}], "size": 2, "snippet_links": [{"key": "finished-product", "type": "definition", "offset": [7, 23]}, {"key": "first-commercial-sale", "type": "clause", "offset": [76, 97]}, {"key": "offer-termination-date", "type": "definition", "offset": [152, 174]}, {"key": "fully-burdened-manufacturing-cost", "type": "definition", "offset": [216, 249]}], "snippet": "5 1.47 Finished Product..............................................5 1.48 First Commercial Sale..........................................5 1.49 First Offer Termination Date...................................5 1.50 Fully Burdened Manufacturing Cost..............................5 1.51 GAAP...........................................................5 1.52", "hash": "a47a1d65bea8700313184943cf1816cd", "id": 5}, {"samples": [{"hash": "2KO5yDJ4cmL", "uri": "/contracts/2KO5yDJ4cmL#financial-appendix", "label": "Placement Agreement", "score": 24.0759753593, "published": true}], "size": 1, "snippet_links": [{"key": "period-of", "type": "definition", "offset": [37, 46]}, {"key": "workplace-training", "type": "clause", "offset": [67, 85]}, {"key": "host-organisation", "type": "definition", "offset": [119, 136]}, {"key": "required-by", "type": "definition", "offset": [177, 188]}, {"key": "management-of", "type": "clause", "offset": [230, 243]}, {"key": "costs-of", "type": "clause", "offset": [259, 267]}, {"key": "training-periods", "type": "clause", "offset": [278, 294]}, {"key": "signed-agreement", "type": "definition", "offset": [348, 364]}], "snippet": "This document is necessary : - for a period of vocational maritime workplace training exceeding two months in a single host organisation, - for a placement under two months, if required by the educational establishment for better management of organisational costs of workplace training periods. The present form has to be filled and sent with the signed agreement. Class : Qualification worked for or towards :", "hash": "56ca043bc3ce02af5b73fa73a3fffae0", "id": 6}, {"samples": [{"hash": "4gFf00615yo", "uri": "/contracts/4gFf00615yo#financial-appendix", "label": "Collaboration Agreement (VG Acquisition Corp.)", "score": 32.3401779603, "published": true}], "size": 1, "snippet_links": [{"key": "general-principles", "type": "clause", "offset": [0, 18]}], "snippet": "General Principles", "hash": "1a0eb431060cceaa2b61cea4db71f691", "id": 7}, {"samples": [{"hash": "gniAlEMv6Fm", "uri": "/contracts/gniAlEMv6Fm#financial-appendix", "label": "Training Agreement", "score": 24.1736247265, "published": true}], "size": 1, "snippet_links": [], "snippet": "Student\u2019s first and last names: Class:", "hash": "1051682f8629993cf29d1c369ccb3c87", "id": 8}, {"samples": [{"hash": "cGj1bpiqpB6", "uri": "/contracts/cGj1bpiqpB6#financial-appendix", "label": "Collaboration, Option and License Agreement (Vividion Therapeutics, Inc.)", "score": 32.3073237509, "published": true}], "size": 1, "snippet_links": [{"key": "the-collaboration", "type": "clause", "offset": [40, 57]}, {"key": "agreement-between", "type": "clause", "offset": [78, 95]}, {"key": "place-of-business", "type": "clause", "offset": [141, 158]}, {"key": "roche-basel", "type": "definition", "offset": [211, 222]}, {"key": "new-jersey", "type": "definition", "offset": [332, 342]}, {"key": "san-diego", "type": "definition", "offset": [530, 539]}, {"key": "the-other-hand", "type": "clause", "offset": [575, 589]}, {"key": "definitions-and", "type": "clause", "offset": [667, 682]}, {"key": "reporting-and-reconciliation", "type": "clause", "offset": [705, 733]}, {"key": "poc-program", "type": "definition", "offset": [778, 789]}, {"key": "with-respect-to", "type": "clause", "offset": [820, 835]}, {"key": "for-the-purposes-of", "type": "clause", "offset": [1009, 1028]}, {"key": "pertaining-to", "type": "definition", "offset": [1092, 1105]}, {"key": "development-of-compounds-and-products", "type": "clause", "offset": [1110, 1147]}, {"key": "shared-products", "type": "definition", "offset": [1183, 1198]}, {"key": "the-territory", "type": "clause", "offset": [1203, 1216]}, {"key": "profits-and-losses", "type": "definition", "offset": [1248, 1266]}, {"key": "in-the-agreement", "type": "clause", "offset": [1328, 1344]}, {"key": "appendix-1", "type": "clause", "offset": [1354, 1364]}, {"key": "terms-not-defined", "type": "definition", "offset": [1366, 1383]}, {"key": "the-meanings", "type": "definition", "offset": [1422, 1434]}, {"key": "agreement-to", "type": "definition", "offset": [1464, 1476]}, {"key": "and-definitions", "type": "clause", "offset": [1689, 1704]}, {"key": "allowable-expense", "type": "definition", "offset": [1781, 1798]}, {"key": "between-the-parties", "type": "clause", "offset": [1856, 1875]}], "snippet": "This Appendix (\u201cFinancial Appendix\u201d) to the Collaboration, Option and License Agreement between F. Hoffmann-La Roche Ltd, with an office and place of business at Grenzacherstrasse 124, 4070 Basel, Switzerland (\u201cRoche Basel\u201d) and Hoffmann-La Roche Inc., with an office and place of business at 150 Clove Road, Suite 8, Little Falls, New Jersey 07424, U.S.A. (\u201cRoche US\u201d; Roche Basel and Roche US together referred to as \u201cRoche\u201d), on the one hand, and Vividion, Inc., with an office and place of business at 5820 Nancy Ridge Drive, San Diego, CA 92121, U.S.A. (\u201cVividion\u201d), on the other hand, effective as of April 3, 2020 (the \u201cAgreement\u201d) addresses certain financial definitions and related principles of reporting and reconciliation to be followed in determining on a Vividion PoC Program-by-Vividion PoC Program basis with respect to each Vividion PoC Program and on a Shared Product-by-Shared-Shared Product basis (but not for any Compounds or Products, under Roche Programs, Optioned Roche Programs), and for the purposes of this Appendix and the Agreement only, the sharing of (a) costs pertaining to the Development of Compounds and Products under Vividion PoC Programs and/or Shared Products for the Territory, as applicable, and (b) Shared Profits and Losses for Shared Products in the US, each (a) and (b) as set forth in the Agreement and this Appendix 1. Terms not defined in this Financial Appendix shall have the meanings set forth in the body of the Agreement to which this Financial Appendix is attached. For each Vividion PoC Program or Shared Product and on a Vividion PoC Program-by-Vividion PoC Program or Shared Product-by-Shared Product basis, the following processes and definitions shall be utilized to calculate, and reimburse or share, as applicable, such Allowable Expense and Shared Profits and Losses (for Shared Products only) between the Parties.", "hash": "1e26dd85fedc84f1c9ec6e3da6af60a6", "id": 9}, {"samples": [{"hash": "6NcKm91fmR0", "uri": "/contracts/6NcKm91fmR0#financial-appendix", "label": "Contract", "score": 20.1211498973, "published": true}], "size": 1, "snippet_links": [], "snippet": "Escalation Formulae Formula: P1 = P0 [ 0,10 + 0,8 (L1 / L0) + 0,10 (M1 / M0) ]", "hash": "54d8eefc79433f9fb2e1fb25927677cd", "id": 10}], "next_curs": "ClsSVWoVc35sYXdpbnNpZGVyY29udHJhY3RzcjcLEhZDbGF1c2VTbmlwcGV0R3JvdXBfdjU2IhtmaW5hbmNpYWwtYXBwZW5kaXgjMDAwMDAwMGEMogECZW4YACAA", "clause": {"size": 18, "children": [], "parents": [["compensation", "Compensation"], ["profit-and-loss-sharing-for-profit-share-products", "Profit and Loss Sharing for Profit Share Products"], ["payments", "Payments"], ["miscellaneous-provisions", "Miscellaneous Provisions"], ["counterparts", "Counterparts"]], "title": "Financial Appendix", "id": "financial-appendix", "related": [["financial-aid", "FINANCIAL AID", "FINANCIAL AID"], ["financial-agreement", "FINANCIAL AGREEMENT", "FINANCIAL AGREEMENT"], ["financial-ability", "Financial Ability", "Financial Ability"], ["subsidy-requests-and-reporting-requirements", "Subsidy Requests and Reporting Requirements", "Subsidy Requests and Reporting Requirements"], ["performance-and-compliance-with-contracts-and-credit-and-collection-policy", "Performance and Compliance with Contracts and Credit and Collection Policy", "Performance and Compliance with Contracts and Credit and Collection Policy"]], "related_snippets": [], "updated": "2025-07-07T12:36:22+00:00", "also_ask": [], "drafting_tip": "", "explanation": "A Financial Appendix is an addendum to a contract that outlines the specific financial terms and details relevant to the agreement. It typically includes information such as payment schedules, pricing structures, invoicing procedures, and any applicable taxes or fees. By consolidating all financial obligations and arrangements in one section, the Financial Appendix ensures transparency and helps prevent misunderstandings or disputes regarding monetary matters between the parties."}, "json": true, "cursor": ""}}